As widely expected, the FDA again rejected the biotechnology outfit's oral version of its drug to treat hypertension. New trials are likely needed.

The charts record the net change in share price, the high, low and closing trades, and share volume for companies with noteworthy stock activity last week. In addition, the graphs depict last week's daily price activity in detail. The dotted line on some graphs denotes the stock's 200-day moving average; lack of a moving average means the shares have traded for less than that time period.